Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

aTyr Pharma Inc (NASDAQ:LIFE)

3.95
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
2.30
Today|||52-Week Range
6.50
+12.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization221.0K226.0K174.0K152.0K
 
 
 
 
 
 
Operating ExpensesGross Income-221.0K-226.0K-174.0K-152.0K
 
 
 
 
 
General Expenses12.3M13.0M11.7M10.7M
 
 
 
 
 
Research And Development9.1M9.2M8.4M7.1M
 
 
 
 
 
Total Operating Expenses12.5M13.2M11.9M10.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.5M-13.2M-11.9M-10.8M
 
 
 
 
 
Extraordinary Charge-29.0K0.000.000.00
 
 
Interest Expense On Debt59.0K------
 
 
Other Expenses0.00-194.0K-231.0K-363.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.6M-13.4M-12.1M-11.2M
 
 
 
 
 
Income Taxes-49.0K0.000.000.00
 
 
Net Income-12.6M-13.4M-12.1M-11.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.7M23.7M23.8M25.8M
 
 
 
 
 
Shares To Calculate EPS Diluted23.7M23.7M23.8M25.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.53-$0.56-$0.51-$0.43
 
 
 
 
 
EPS Diluted-$0.53-$0.56-$0.51-$0.43